NFATC1 and lymphoma: Nuclear localization of NFATc1 was significantly downregulated in the lymphoma cells of two patients (cases #1 and #2) who achieved partial remission and CR at 4.00 and 7.00 months, respectively, after the completion of HPE (Fig. 3).